¡¡µ­»ö¥¿¥¤¥È¥ë¡§IV·¿¤Ïͽ¸å¤¬Îɤ¤¡©¡¡


½ñ¤­¹þ¤ßÍó¤Ø ¡¡¥Ø¥ë¥×
¤ªÌ¾Á°¡§ ³á»³ ¡¡¡¡
³ùëÀèÀ¸¤Î¸æ»ØŦ¤ÎÄ̤ꡢKidney International vol59, 2001, 
2156-2163¤Ë¡¢·ìÀ¶¥¯¥ì¥¢¥Á¥Ë¥ó¤¬Cr1.4°Ê²¼¤Ë¤Ê¤ê¡¢¤«¤ÄÇ¢ÃÁ
Çò¤¬0.33g/day°Ê²¼¤Ë¤Ê¤ë¤³¤È¤ò´²²ò¤ÈÄêµÁ¤·¡¢¤Þ¤¿¡¢·ìÀ¶¥¯¥ì
¥¢¥Á¥Ë¥ó¤¬6mg/dl°Ê¾å¤Ë¤Ê¤ë¤«Æ©ÀÏƳÆþ¤ò¿Õ»à¤ÈÄêµÁ¤·¤Æ¡¢
´²²òΨ¤Èrenal survival¤ò¤ß¤Æ¤ª¤ê¡¢³Î¤«¤Ë¡¢ª¤·¿¤ÎÊý¤¬ª£·¿¡¢
ª¥·¿¤è¤êͽ¸å¤¬¤è¤¤¤È¤·¤Æ¤¤¤Þ¤¹¡£¤¿¤À¤·¤³¤³¤Ç¸À¤¦ª¥·¿¤È¤Ï¡¢
ª£·¿ª¤·¿¤ÎÉÂÊѤËmembranous type¤ÎÉÂÊѤ¬superimpose¤·¤¿
ª¥c(ª£superimposed),ª¥d(ª¤superimposed)¤â¤Î¤Ç¤¢¤ê¡¢pure
 membranous ¤Ç¤ÏÍ­¤ê¤Þ¤»¤ó¡£pure membranous¤Ïª¥a¤Ç¤¢¤ê¡¢
ª¥a¤Ç¤¢¤ì¤Ðͽ¸å¤Ï¤À¤¤¤Ö°Û¤Ê¤ë¤È»×¤¤¤Þ¤¹¡£¼£ÎÅË¡¤â¤â¤Á¤í¤ó
°Û¤Ê¤ê¤Þ¤¹¡£
¡¡¤â¤¦¾¯¤·ÀºÆɤ·¤Æ¤Þ¤¿¸æÊó¹ðÃפ·¤Þ¤¹¡£
[2002ǯ5·î9Æü 10»þ58ʬ3ÉÃ]

¤ªÌ¾Á°¡§ ³ùëľǷ ¡¡¡¡
SLE¤Î¿Õ¾É¤ÇWHO IV·¿¤Ï´²²ò¤Ë¤Ê¤ê¤ä¤¹¤¤¤Î¤Ç
III¡¢V·¿¤è¤êͽ¸å¤¬Îɤ¤¤È¤¤¤¦Êó¹ð¤â¤¢¤ë¤½¤¦¤Ç¤¹¡£
ËÜÅö¤Ç¤¹¤«¡©

Cox-2Á˳²Ìô¤Ç¿´¶Ú¹¼ºÉ¡¢¶¹¿´¾É¤¬Áý¤¨¤ë¤È¤¤¤¦Àâ¤â¤¢¤ë¤½¤¦¤Ç¤¹¡£
ËÜÅö¤Ç¤¹¤«¡©

¥á¥Á¥³¥Ð¡¼¥ë¤¬Ëö¾¿¿À·Ð¾ã³²¤Ë¸ú²Ì¤¬¤¢¤ë¤È¤¤¤¦evidence¤Ï¤¢¤ê¤Þ¤¹¤«¡©
[2002ǯ5·î8Æü 17»þ37ʬ51ÉÃ]

¤³¤Î¥Æ¡¼¥Þ¤Ë¤Ä¤¤¤Æ¤Îȯ¸À¤ò¤É¤¦¤¾¡£
»á̾
E-mail URL
¢¨¡¡½ñ¤­¹þ¤ß¤Ï¤´¼«Ê¬¤¬¤¤¤ì¤¿²þ¹Ô¡Ü¥«¥é¥àü¤Ç¤â¼«Æ°²þ¹Ô¤µ¤ì¤Þ¤¹¡£

¢¨È¾³Ñ¥«¥Ê¤Ï»ÈÍѤ·¤Ê¤¤¤è¤¦¤Ë¤·¤Æ¤¯¤À¤µ¤¤¡£Ê¸»ú²½¤±¤·¤Þ¤¹¡£
µ­»ö°ìÍ÷¤ËÌá¤ë